HSIC vs MRK
Henry Schein vs Merck & Co. — AI-powered side-by-side comparison
| Metric | HSIC | MRK |
|---|
| AI Score |
67
|
70
|
| Price |
$89.16
|
$130.34
|
| P/E Ratio |
25.77×
|
103.53×
|
| ROE |
12.3%
|
34.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
30.3%
|
75.4%
|
| Debt / Equity |
1.21×
|
1.29×
|
| Dividend Yield |
0.0%
|
2.6%
|
| RSI (14) |
59.4
|
64.5
|
| Beta |
0.808
|
0.207
|
| Expected Upside |
+0.8%
|
—
|
AI Committee View
Current Innellis committee reasoning for HSIC versus MRK.
MRK leads by 3 points.
MRK scores 70/100 (Buy) versus HSIC at 67/100 (Buy).
HSIC Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
MRK Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical